vs

Side-by-side financial comparison of BayFirst Financial Corp. (BAFN) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.

BayFirst Financial Corp. is the larger business by last-quarter revenue ($10.3M vs $8.6M, roughly 1.2× Sunshine Biopharma Inc.). Sunshine Biopharma Inc. runs the higher net margin — -25.0% vs -55.0%, a 30.0% gap on every dollar of revenue. Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -29.6%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.

BAFN vs SBFM — Head-to-Head

Bigger by revenue
BAFN
BAFN
1.2× larger
BAFN
$10.3M
$8.6M
SBFM
Higher net margin
SBFM
SBFM
30.0% more per $
SBFM
-25.0%
-55.0%
BAFN
Faster 2-yr revenue CAGR
SBFM
SBFM
Annualised
SBFM
6.6%
-29.6%
BAFN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BAFN
BAFN
SBFM
SBFM
Revenue
$10.3M
$8.6M
Net Profit
$-5.7M
$-2.1M
Gross Margin
35.3%
Operating Margin
-20.9%
Net Margin
-55.0%
-25.0%
Revenue YoY
-10.6%
Net Profit YoY
-130.6%
0.8%
EPS (diluted)
$-1.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAFN
BAFN
SBFM
SBFM
Q1 26
$10.3M
Q4 25
$11.2M
$8.6M
Q3 25
$10.2M
$9.4M
Q2 25
$23.1M
$9.4M
Q1 25
$19.8M
$8.9M
Q4 24
$32.9M
$9.6M
Q3 24
$21.7M
$8.4M
Q2 24
$20.8M
$9.3M
Net Profit
BAFN
BAFN
SBFM
SBFM
Q1 26
$-5.7M
Q4 25
$-2.5M
$-2.1M
Q3 25
$-18.9M
$-883.8K
Q2 25
$-1.2M
$-1.8M
Q1 25
$-335.0K
$-1.2M
Q4 24
$9.8M
$-2.2M
Q3 24
$1.1M
$-1.2M
Q2 24
$866.0K
$-494.3K
Gross Margin
BAFN
BAFN
SBFM
SBFM
Q1 26
Q4 25
35.3%
Q3 25
32.6%
Q2 25
36.4%
Q1 25
30.7%
Q4 24
32.2%
Q3 24
34.0%
Q2 24
25.3%
Operating Margin
BAFN
BAFN
SBFM
SBFM
Q1 26
Q4 25
-25.3%
-20.9%
Q3 25
-253.0%
-11.5%
Q2 25
-7.1%
-21.8%
Q1 25
-2.3%
-14.6%
Q4 24
-21.7%
Q3 24
7.1%
-13.1%
Q2 24
5.9%
-13.6%
Net Margin
BAFN
BAFN
SBFM
SBFM
Q1 26
-55.0%
Q4 25
-22.1%
-25.0%
Q3 25
-184.7%
-9.4%
Q2 25
-5.3%
-18.8%
Q1 25
-1.7%
-13.3%
Q4 24
91.8%
-22.5%
Q3 24
5.2%
-14.2%
Q2 24
4.2%
-5.3%
EPS (diluted)
BAFN
BAFN
SBFM
SBFM
Q1 26
$-1.48
Q4 25
$-0.71
Q3 25
$-4.66
$-0.54
Q2 25
$-0.39
$-0.82
Q1 25
$-0.17
$-0.44
Q4 24
$2.21
$49.77
Q3 24
$0.18
$-11.61
Q2 24
$0.12
$-43.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAFN
BAFN
SBFM
SBFM
Cash + ST InvestmentsLiquidity on hand
$134.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$81.9M
$23.0M
Total Assets
$1.2B
$30.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAFN
BAFN
SBFM
SBFM
Q1 26
$134.5M
Q4 25
$207.0M
Q3 25
$118.5M
Q2 25
$77.3M
Q1 25
$63.2M
Q4 24
$77.8M
Q3 24
$64.4M
Q2 24
$60.8M
Stockholders' Equity
BAFN
BAFN
SBFM
SBFM
Q1 26
$81.9M
Q4 25
$87.6M
$23.0M
Q3 25
$89.7M
$24.2M
Q2 25
$108.2M
$25.7M
Q1 25
$110.1M
$22.7M
Q4 24
$110.9M
$23.5M
Q3 24
$102.3M
$25.0M
Q2 24
$101.0M
$23.5M
Total Assets
BAFN
BAFN
SBFM
SBFM
Q1 26
$1.2B
Q4 25
$1.3B
$30.1M
Q3 25
$1.3B
$31.5M
Q2 25
$1.3B
$32.0M
Q1 25
$1.3B
$29.2M
Q4 24
$1.3B
$30.6M
Q3 24
$1.2B
$30.1M
Q2 24
$1.2B
$29.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAFN
BAFN
SBFM
SBFM
Operating Cash FlowLast quarter
$-1.6M
Free Cash FlowOCF − Capex
$-1.6M
FCF MarginFCF / Revenue
-18.9%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAFN
BAFN
SBFM
SBFM
Q1 26
Q4 25
$285.3M
$-1.6M
Q3 25
$47.3M
$-727.8K
Q2 25
$63.3M
$-1.3M
Q1 25
$74.2M
$-1.7M
Q4 24
$390.5M
$-3.4M
Q3 24
$90.8M
$-1.4M
Q2 24
$78.8M
$-4.6M
Free Cash Flow
BAFN
BAFN
SBFM
SBFM
Q1 26
Q4 25
$285.0M
$-1.6M
Q3 25
$47.3M
$-735.8K
Q2 25
$63.1M
$-1.4M
Q1 25
$74.1M
$-1.7M
Q4 24
$388.8M
$-3.5M
Q3 24
$90.5M
$-1.9M
Q2 24
$78.4M
$-5.6M
FCF Margin
BAFN
BAFN
SBFM
SBFM
Q1 26
Q4 25
2554.2%
-18.9%
Q3 25
462.2%
-7.8%
Q2 25
272.7%
-15.2%
Q1 25
375.1%
-19.3%
Q4 24
1180.9%
-36.6%
Q3 24
416.5%
-22.2%
Q2 24
376.1%
-59.7%
Capex Intensity
BAFN
BAFN
SBFM
SBFM
Q1 26
Q4 25
2.7%
0.0%
Q3 25
0.1%
0.1%
Q2 25
0.8%
1.7%
Q1 25
0.4%
0.1%
Q4 24
5.1%
1.1%
Q3 24
1.5%
6.1%
Q2 24
1.9%
10.5%
Cash Conversion
BAFN
BAFN
SBFM
SBFM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
39.95×
Q3 24
79.85×
Q2 24
90.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAFN
BAFN

Net Interest Income$9.4M91%
Noninterest Income$884.0K9%

SBFM
SBFM

Segment breakdown not available.

Related Comparisons